Fibrocell

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Fibrocell and buy or sell other stocks, ETFs, and their options commission-free!

About FCSC

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. 

CEO
John M. Maslowski
CEOJohn M. Maslowski
Employees
Employees
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1995
Founded1995
Employees
Employees

FCSC Key Statistics

Market cap
29.27M
Market cap29.27M
Price-Earnings ratio
-12.91
Price-Earnings ratio-12.91
Dividend yield
Dividend yield
Average volume
66.51K
Average volume66.51K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.28
52 Week high$3.28
52 Week low
$1.45
52 Week low$1.45

Stock Snapshot

The current Fibrocell(FCSC) stock price is $3.00, with a market capitalization of 29.27M. The stock trades at a price-to-earnings (P/E) ratio of -12.91.

Fibrocell(FCSC) stock opened on 2026-03-03 at —. The price climbed to — and dipped to —.

Fibrocell(FCSC) shares are trading with a volume of 0, against a daily average of 66.51K.

During the past year, Fibrocell(FCSC) stock moved between $1.45 at its lowest and $3.28 at its peak.

During the past year, Fibrocell(FCSC) stock moved between $1.45 at its lowest and $3.28 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.